7-benzylamino-6-chloro-2-piperazino-4-pyrrolidinopteridine has been researched along with (pPNET) Peripheral Primitive Neuroectodermal Tumors in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Augusti-Tocco, G; Campagnolo, L; Giorgi, M | 1 |
1 other study(ies) available for 7-benzylamino-6-chloro-2-piperazino-4-pyrrolidinopteridine and (pPNET) Peripheral Primitive Neuroectodermal Tumors
| Article | Year |
|---|---|
Phosphodiesterase specific inhibitors control cell growth of a human neuroepithelioma cell line.
Topics: Cell Division; Humans; Neuroectodermal Tumors, Primitive, Peripheral; Phosphodiesterase Inhibitors; Piperazines; Pteridines; Purinones; Pyrrolidinones; Rolipram; Tumor Cells, Cultured | 1997 |